Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard D. Brounstein currently holds 102,075 shares of CALYPTE BIOMEDICAL CORP (CBMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard D. Brounstein has been a net buyer of CBMC stock. They have purchased $46.8K and sold $0 worth of shares.
Richard D. Brounstein's most recent insider trade was on Dec 21, 2021, when they purchased 5,000 shares at $3.37 per share.
Richard D. Brounstein serves as Executive at CALYPTE BIOMEDICAL CORP (CBMC). They have executed 5 insider transactions totaling $46.8K over their tenure at the company.
Richard D. Brounstein holds the position of Executive at CALYPTE BIOMEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Richard D. Brounstein has shown a buying trading pattern, with $46.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Richard D. Brounstein was on Mar 28, 2007, when they sold $192.3K worth of CBMC shares. This transaction involved 3,846,154 shares at $0.05 per share.
Richard D. Brounstein currently owns 102,075 shares of CALYPTE BIOMEDICAL CORP (CBMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard D. Brounstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard D. Brounstein has 5 Form 4 filings on record as an insider at CALYPTE BIOMEDICAL CORP.
Set alerts for Richard D. Brounstein and 40,000+ other insiders.